Authors
Latest:
Influenza vs the Common Cold: Symptoms and TreatmentPatients may find it difficult to distinguish between a cold and the flu, and pharmacists can help them determine if self treatment is appropriate.
Latest:
Pharmacist Provider Status Is Growing. Now What?Throughout a new graduate’s career, that provider status will become mainstream.
Latest:
Healthcare Utilization and Costs for Insured Patients With FibromyalgiaFibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
Latest:
Adult Immunizations: Are Your Patients Up-to-Date?In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
Latest:
Initiating Drug Therapy in Multiple Sclerosis Patients: Effect on Healthcare CostsMultiple sclerosis (MS) is a disease of inflammatory demyelination of axons of the central nervous system that results in episodes of transient neurologic deficits, progressing to permanent neurologic deterioration over time.1 The cause of MS remains unclear, but it is thought to involve both genetic susceptibility and environmental triggers, possibly viral, which result in self-sustaining autoimmune dysfunction.
Latest:
How Zero-Error E-Prescribing Can Help Pharmacists as They Begin COVID-19 VaccinationsAs administration of COVID-19 begins, pharmacies are preparing to vaccinate millions of people, not only once but twice.
Latest:
Securing Specialty Oncology Contracts in a Data-Driven WorldData aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
Latest:
Total Store Expo, Take 2NACDS anticipates another successful conference in Boston this August.
Latest:
Combo Inhibitor Antibiotic Approved to Treat HABP/VABPThe US Food and Drug Administration has approved Allergan's supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa, and Haemophilus influenzae in patients 18 years of age or older.
Latest:
New Insulin Products and Best PracticesEven with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.
Latest:
Postoperative Pain ManagementPostoperative pain management presents a major challenge to patients and health care providers.
Latest:
Keeping a Healthy Brain in the Midst of COVID-19In addition to allopathic or prescription medications to manage depression stemming from this pandemic, there are integrative medicines, as well as health and wellness modalities, that can be used to improve mental health.
Latest:
NAPLEX Preparation: Tips for the Most Important Exam of Your CareerBefore you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.
Latest:
Pharmacist Collaborative Management of Poorly Controlled Diabetes Mellitus: A Randomized Controlled TrialDiabetes mellitus affects 23 million people in the United States. Adjusting for population age differences, survey data between 2004 and 2006 indicate that 6.6% of non-Hispanic whites, 7.5% of Asian Americans, 10.4% of Hispanics, and 11.8% of non-Hispanic blacks have diabetes mellitus.1 Totaling $174 billion in 2007, diabetes care accounts for 19% of total healthcare costs.
Latest:
The Impact of Health Care ReformThe 2010 health care reforms affect the daily practices of pharmacists, especially as generic drugs play an even greater role in the cost containment of health care for millions of Americans.
Latest:
From Iowa to Asheville and Back: An Accountable Care Perspective from the TrenchesNew care team models are springing up across the country.
Latest:
Cancer Patients Require Coordinated CareTreatment advances have made many cancers a chronic disease rather than a terminal disease. Here is how one dedicated team works to coordinate care and work with patients.
Latest:
The Evolving World of Pharma MarketingPharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.
Latest:
Devices Made Easy: A Review of Inhaler Technique and Patient Adherence in COPDThis Continuing Education activity is supported by educational grants from AstraZeneca LP and Boehringer Ingelheim Pharmaceuticals, Inc.
Latest:
Payers' Views on the Heterogeneity of Treatment Effect in OncologyWhen making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
Latest:
Health Information Technology: Supporting Pharmacy Trends in 2014Four major trends will dominate the health information technology landscape during the coming year.
Latest:
Health-System Specialty Pharmacies Address Social Determinants of HealthIntegrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.
Latest:
Techs Taking More Active Role in Preventing PoisoningsPharmacy team members can provide educational resources, strategies to kids to promote safety.
Latest:
Comparison of Pharmacists and Primary Care Providers as ImmunizersPharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
Latest:
Viability of a Dose Optimization Program Within a Specialty PharmacyDose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
Latest:
Vaccines: There Is an App for ThatThese 8 apps, offered by organizations such as the pediatric infectious diseases society and the CDC, feature vaccine schedules, risks, and more.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
